Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 21 Apr 2026 for Nuvation Bio Inc., €213k.
Filing timeline
BuySaleDongfang Liu
Insider track record
Disclosed buys
0
Disclosed sells
8
Signal history
Dongfang Liu: trading record in brief
Dongfang Liu discloses dealings in Nuvation Bio Inc. to SEC (Form 4). Between 2 May 2025 and 17 April 2026, the trades on record add up to 16 filings.
No open-market purchase appears, only 8 sales worth €1.7M. Besides market trades, the filings include 8 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
The newest entry dates from 21 April 2026: an open-market sale of €213k, in Nuvation Bio Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Dongfang Liu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
50,000 shares@ US$5.020.012% mcap26.7% of flowClass A Common StockSEC:0001937915-26-000004:1
50,000 shares@ US$1.940.0048% mcap10.3% of flowClass A Common StockSEC:0001937915-26-000004:0
150,000 shares@ US$2.9347.6% of flowClass A Common StockSEC:0001937915-25-000010:0
10,000 shares@ US$3.613.9% of flowClass A Common StockSEC:0001937915-25-000008:0
20,000 shares@ US$1.874.1% of flowClass A Common StockSEC:0001937915-25-000006:0
15,000 shares@ US$1.873.0% of flowClass A Common StockSEC:0001937915-25-000004:0
20,000 shares@ US$1.944.3% of flowClass A Common StockSEC:0001415889-25-012096:0
7 of 7 declarations
